The company's sales revenue also rose by 8% year-on-year to 572.2 million levs in the January-September period of 2019, Sopharma Trading said in a bourse filing.
In September alone, Sopharma Trading's profit before taxes fell to 1.46 million levs from 2.28 million levs reported in September 2018. Sales revenue in September added 4% year-on-year to 62.5 million levs.
As at 13:25 CET on Monday, Sopharma Trading shares traded 0.83% lower at 5.95 levs on the Bulgarian Stock Exchange.
Sopharma Trading is a unit of Bulgarian drug maker Sopharma [BUL:3JR].
(1 euro = 1.95583 levs)